Reduction of cortactin, an actin-binding protein reduced in IBD patients, upregulates RhoA/Rho-associated protein kinase (ROCK) signaling to phosphorylate myosin light chain, which contracts actomyosin leading to altered TJs and increased epithelial permeability [42]. Here, RHOA is linked to inflammatory bowel disease.